*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
Lisa Tuttle
Office of Stephen Cross
Executive Vice President for Research
Georgia Tech
Summary Sentence: M.G. Finn, Ph.D. - Georgia Tech
Full Summary: No summary paragraph submitted.
M.G. Finn, Ph.D. - Georgia TechM.G. Finn, Ph.D.
Professor and Chair
James A. Carlos Family Chair for Pediatric Technology
School of Chemistry and Biochemistry
Georgia Tech
Research:
In the Finn lab, we develop chemical and biological tools for research in a wide range of fields. Some of them are briefly described below; please see our group web page for more details.
Chemistry, biology, immunology, and evolution with viruses. The sizes and properties of virus particles put them at the interface between the worlds of chemistry and biology. We use techniques from both fields to tailor these particles for applications to cell targeting, diagnostics, vaccine development, catalysis, and materials self-assembly. This work involves combinations of small-molecule and polymer synthesis, bioconjugation, molecular biology, protein design, protein evolution, bioanalytical chemistry, enzymology, physiology, and immunology. It is an exciting training ground for modern molecular scientists and engineers.
Development of reactions for organic synthesis, chemical biology, and materials science. Molecular function is what matters most to our scientific lives, and good chemical reactions provide the means to achieve such function. We continue our efforts to develop and optimize reactions that meet the click chemistry standard for power and generality. Our current focus is on highly reliable reversible reactions, which open up new possibilities for polymer synthesis and modification, as well as for the controlled delivery of therapeutic and diagnostic agents to biological targets.
Traditional and combinatorial synthesis of biologically active compounds. We have a longstanding interest in the development of biologically active small molecules. We work closely with industrial and academic collaborators on such targets as antiviral agents, compounds to combat tobacco addiction, and treatments for inflammatory disease.
